About Sapiens Neuro
Sapiens Neuro is a company based in Munchen (Germany) founded in 2011 was acquired by Medtronic in August 2014. Sapiens Neuro has raised $55.91 million across 4 funding rounds from investors including Medtronic, Edmond de Rothschild and Life Sciences Partners. Sapiens Neuro operates in a competitive market with competitors including PhotoPharmics, Cala Health, Civitas Therapeutics, Charco Neurotech and Aleva Neuro, among others.
- Headquarter Munchen, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sapiens Neuro
Sapiens Neuro has successfully raised a total of $55.91M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $23 million completed in November 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sapiens Neuro
Sapiens Neuro has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Edmond de Rothschild and Life Sciences Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AI, deeptech, and healthcare tech companies are funded by Inkef.
|
Locked | Locked | Locked | |
|
Investments are made in early-stage healthcare startups.
|
Locked | Locked | Locked | |
|
Private equity investments in life sciences businesses are managed.
|
Locked | Locked | Locked |
Investor details for Sapiens Neuro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sapiens Neuro
Investment portfolio details for Sapiens Neuro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sapiens Neuro
Detailed financials for Sapiens Neuro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sapiens Neuro Comparisons
Peer comparison for Sapiens Neuro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sapiens Neuro
Sapiens Neuro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PhotoPharmics, Cala Health, Civitas Therapeutics, Charco Neurotech and Aleva Neuro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive phototherapy for Parkinson's disease is developed.
|
|
| Locked | Locked | Locked |
Wearable neuromodulation devices for essential tremor relief are developed.
|
|
| Locked | Locked | Locked |
Inhaled pulmonary therapies for Parkinson's motor fluctuations are developed.
|
|
| Locked | Locked | Locked |
Non-invasive wearable devices for Parkinson's management are developed.
|
|
| Locked | Locked | Locked |
Implantable deep brain stimulation systems are developed for neurological diseases.
|
Detailed competitors of Sapiens Neuro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sapiens Neuro
Complete news archive for Sapiens Neuro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sapiens Neuro
Sapiens Neuro was founded in 2011.
Sapiens Neuro is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Sapiens Neuro is a funded company, having raised a total of $55.91M across 4 funding rounds to date.
Developer of brain stimulation device to treat neurodegenerative disorders. The company develops a Deep Brain Stimulating (DBS) therapy device that comprises image-guided programming technology for the treatment of Parkinsons disease.
Sapiens Neuro's top competitors include PhotoPharmics, Cala Health and Aleva Neuro.
Sapiens Neuro has 6 investors. Key investors include Medtronic, Edmond de Rothschild, Life Sciences Partners, Inkef, and Wellcome.